Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 197 results for "lupin ltd"

Lupin tanks 3%; receives USFDA nod for generic Namenda XR Capsules
India Infoline

Lupin gaining traction, Buy for a target of Rs 1640: Sacch...

Sacchitanand Uttekar of Motilal Oswal Financial Services has given a buy on Lupin Ltd. at Rs 1512.75 as trading volumes surged to 19313 over previous day. Analyst gave the target of Rs 1640 and a stop loss of Rs 1420 . The analyst gave 1-3 days for ... Economic Times, 2 days ago

9 images for lupin ltd

Financial Express, 2 months ago
India Infoline, 2 months ago, 5 months ago, 5 months ago
India Infoline, 4 months ago
India Infoline, 3 months ago
Forbes India, 5 months ago, 5 months ago
Siasat Daily, 5 months ago

BRIEF-Lupin, Boehringer Ingelheim India to co-market diabetes drug Empagliflozin

n"Oct 13 Lupin Ltd * Lupin Ltd - type 2 diabetes: Boehringer Ingelheim India and Lupin announce strategic co-marketing agreement * Lupin Ltd says will market, sell Empagliflozin under separate brand name Gibtulio * Lupin Ltd says - Boehringer will ...
 Reuters UK1 week ago Lupin in pact with Boehringer Ingelheim to market diabetic drug  Livemint.com1 week ago Boehringer Ingelheim, Lupin sign pact for diabetes drug  Financial Express1 week ago Lupin, Boehringer Ingelheim India to co-market diabetes drug Empagliflozin  Pharma Focus Asia1 week ago

Lupin, BC Partners shortlisted for Bayer's $1.1 bn dermatology business

India's fourth-largest drug maker by sales, Lupin Ltd, and private equity firm BC Partners have been shortlisted as prospective buyers for German chemicals and drugmaker Bayer AG's dermatology business worth around €1 billion ($1.1 billion). ...
 Domain-B1 week ago Lupin gets nod for a new indigestion drug  Livemint.com2 months ago LUPIN : gets approval for new indigestion tablets in India  4 Traders2 months ago LUPIN : Gets nod for indigestion tablets  4 Traders2 months ago

Lupin's Q2 Results on November 09, 2016

Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 09, 2016, inter alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2016.
 Money Control1 week ago Lupin Ltd to announce Q2 Results on November 09, 2016  Equity Bulls1 week ago Lupin Q1 net profit soars to Rs. 881.95 crores  Equity Bulls2 months ago

Lupin Ltd approves allotment of 103120 shares under ESOP

Posted On: 2016-10-21 23:33:18 The Allotment Committee of Directors of Lupin Ltd at its meeting held on October 21, 2016 has allotted 103120 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options ...
 Equity Bulls4 days ago Lupin Ltd allots 69639 shares under ESOP  Equity Bulls4 weeks ago Lupin Ltd allots 89183 shares under ESOP  Equity Bulls2 months ago
India Infoline

Top 17 stocks in focus today: Infosys, TCS, Lupin

Check out the companies which will be in focus during trade today based on recent and latest news developments. Infosys Ltd: The IT Company will announce its Q2 numbers today. Reliance Industrial Infrastructure Ltd: The company reported 19% ...
 India Infoline1 week ago Opening bell | Infosys earnings today; TCS, Hindustan Unilever in focus  Livemint.com1 week ago Top 14 stocks in focus today: Orient Cement, IDBI Bank, ABG Shipyard  India Infoline2 weeks ago
Financial Express

Sun Pharma, India's best performing stock in last 20 years, on track for worst annual decline since 2008

One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceuticals Industries Ltd. calling more than 100 times over three years with a job offer two decades ago. In the end, Shanghvi won over Lanka, who agreed to leave his job at global ...
 Financial Express1 week ago Dilip Shanghvi, Man Behind India's Best Stock, Now Faces His Greatest Test  NDTV1 week ago M&A artist behind India's best stock now faces his greatest test  DealStreetAsia1 week ago With Sun Pharma set for its steepest fall, Dilip Shanghvi faces his biggest test  Economic Times1 week ago

Domestic market revives, but US woes to hit pharma firms earnings

Analysts see overall sales growth of 7-10% for the pharma industry in the September quarter, but profits are likely to be under pressure The lucrative US drug market has become challenging for Indian companies because of regulatory issues, product ...
 Livemint.com1 day ago

DoP quashes ceiling price of levoflexacin 500 mg by NPPA; directs to refix ceiling price as per DPCO

The Department of Pharmaceuticals (DoP) has quashed the ceiling price fixation of levoflexacin 500 mg by NPPA, dated 29.03.2016, which the DoP has found to be in deviation of DPCO, 2013. The DoP has then directed the NPPA to refix the ceiling price ...
 PharmaBiz2 days ago

India stocks higher at close of trade; Nifty 50 up 0.47%

Reuters. India stocks were higher after the close on Thursday, as gains in the Banking, Metals and Real Estate sectors led shares higher. At the close in NSE, the Nifty 50 rose 0.47%, while the BSE Sensex 30 index added 0.52%. The best ...
 Investing.com6 days ago India stocks lower at close of trade; Nifty 50 down 0.19%  Investing.com4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less